Vizsgálati helyszín

Royal Cornwall Hospital

Truro, TR1 3LQ, Egyesült KirályságMég nincs intézményhez kötve

33futó vizsgálat
13lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 46 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Áttétes emlőrák6 vizsgálat
Gyermekkori daganatok4 vizsgálat
Prosztatarák4 vizsgálat
Stroke (szélütés)4 vizsgálat
Tüdőrák4 vizsgálat
Diffúz nagy B-sejtes limfóma (DLBCL)3 vizsgálat
Köpenysejtes limfóma3 vizsgálat
Gyomor- és nyelőcsőrák2 vizsgálat
Hodgkin-limfóma2 vizsgálat
Koszorúér-betegség2 vizsgálat
Krónikus vesebetegség2 vizsgálat
Méhnyakrák2 vizsgálat
és még 17
Fázis: 3. fázis29 vizsgálat
2. fázis8 vizsgálat
4. fázis1 vizsgálat
Állapot: Fut, nem toboroz18 vizsgálat
Toboroz15 vizsgálat
Lezárult12 vizsgálat
Leállították1 vizsgálat
Fő szponzor: Hoffmann-La Roche7 vizsgálat
University College, London5 vizsgálat
Boehringer Ingelheim3 vizsgálat
BioNTech SE2 vizsgálat
Daiichi Sankyo2 vizsgálat
és még 21

Futó vizsgálatok

Toboroz
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
NCT07393282· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
NCT07282574· 2. fázis· Hoffmann-La Roche· Forrás
Toboroz
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521· 3. fázis· Relay Therapeutics, Inc.· Forrás
Contact: Relay Therapeutics, Inc
Toboroz
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
NCT06340568· 3. fázis· BioNTech SE· Forrás
Toboroz
To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
NCT06849284· Royal Cornwall Hospitals Trust· Forrás
Contact: Verity Teague
Fut, nem toboroz
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)
NCT06440174· University Hospital Southampton NHS Foundation Trust· Forrás
Contact: Sally Thomas
Toboroz
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
NCT05635162· 2. fázis· University College, London· Forrás
Contact: Michelle Furtado
Fut, nem toboroz
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
NCT05004064· 2. fázis· University College, London· Forrás
Toboroz
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
NCT05920356· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
NCT04920708· 2. fázis· Royal Marsden NHS Foundation Trust· Forrás
Toboroz
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
NCT05613023· 3. fázis· Institute of Cancer Research, United Kingdom· Forrás
Contact: John McGrane
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
NCT05296798· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT05085028· 3. fázis· Imperial College London· Forrás
Contact: Grant Stewart
Fut, nem toboroz
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
NCT05201547· 3. fázis· ARCAGY/ GINECO GROUP· Forrás
Toboroz
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT04685616· 3. fázis· University College, London· Forrás
Contact: Bryson Pottinger
Fut, nem toboroz
Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
NCT04546620· 2. fázis· University Hospital Southampton NHS Foundation Trust· Forrás
Toboroz
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
NCT04774159· 3. fázis· Population Health Research Institute· Forrás
Contact: Abhijeet Patil
Fut, nem toboroz
Observational Clinical Investigation of Arthrosamid in Knee Osteoarthritis
NCT05057559· Contura· Forrás
Fut, nem toboroz
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494· 3. fázis· Genmab· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
NCT04546009· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NCT04204915· University of Leicester· Forrás
Contact: Dr Mohammed Abubakr
Fut, nem toboroz
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
NCT03888105· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
NCT04116502· 3. fázis· University of Birmingham· Forrás
Contact: Natalia Morelli
Fut, nem toboroz
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
NCT02804815· 3. fázis· University College, London· Forrás
Fut, nem toboroz
Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems
NCT02314702· MicroPort Orthopedics Inc.· Forrás
Fut, nem toboroz
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT02446405· 3. fázis· University of Sydney· Forrás
Fut, nem toboroz
Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
NCT01761968· 2. fázis· Italfarmaco· Forrás
Fut, nem toboroz
Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer
NCT01566240· 3. fázis· University College, London· Forrás
Fut, nem toboroz
Prostate Advances in Comparative Evidence
NCT01584258· 3. fázis· Royal Marsden NHS Foundation Trust· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Lezárt vizsgálatok

Lezárult
A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
NCT04526899· 2. fázis· BioNTech SE· Forrás
Lezárult
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
NCT04256421· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
NCT03950076· 4. fázis· Population Health Research Institute· Forrás
Lezárult
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
NCT03762018· 3. fázis· ETOP IBCSG Partners Foundation· Forrás
Lezárult
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
NCT03782207· Hoffmann-La Roche· Forrás
Lezárult
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
NCT03594110· 3. fázis· Boehringer Ingelheim· Forrás
Leállították
The MyoVista Angiography Angioplasty Percutaneous Coronary Intervention Trial
NCT03635801· Royal Cornwall Hospitals Trust· Forrás
Lezárult
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
NCT03734029· 3. fázis· Daiichi Sankyo· Forrás
Lezárult
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
NCT03523585· 3. fázis· Daiichi Sankyo· Forrás
Lezárult
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
NCT03599245· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
NCT02908672· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
NCT02898610· 3. fázis· University College Dublin· Forrás
Lezárult
Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT01658930· Canadian Cancer Trials Group· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 14.

Hibát jelzek